Compare BNS & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BNS | MDT |
|---|---|---|
| Founded | 1832 | 1949 |
| Country | Canada | Ireland |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 91.7B | 131.9B |
| IPO Year | 2024 | 2014 |
| Metric | BNS | MDT |
|---|---|---|
| Price | $75.07 | $85.65 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 20 |
| Target Price | $106.00 | ★ $109.22 |
| AVG Volume (30 Days) | 2.5M | ★ 7.0M |
| Earning Date | 05-26-2026 | 06-03-2026 |
| Dividend Yield | ★ 4.22% | 3.26% |
| EPS Growth | N/A | ★ 30.80 |
| EPS | N/A | ★ 2.76 |
| Revenue | N/A | ★ $33,537,000,000.00 |
| Revenue This Year | $26.54 | $8.91 |
| Revenue Next Year | $4.77 | $6.77 |
| P/E Ratio | ★ $18.76 | $31.58 |
| Revenue Growth | N/A | ★ 3.62 |
| 52 Week Low | $47.06 | $79.93 |
| 52 Week High | $78.28 | $106.33 |
| Indicator | BNS | MDT |
|---|---|---|
| Relative Strength Index (RSI) | 65.78 | 37.07 |
| Support Level | $75.01 | $85.35 |
| Resistance Level | $78.04 | $89.01 |
| Average True Range (ATR) | 1.02 | 1.58 |
| MACD | 0.81 | 0.35 |
| Stochastic Oscillator | 95.16 | 18.11 |
The Bank of Nova Scotia is a global financial services provider with over CAD 1.46 trillion in assets as of the end of fiscal 2025. The bank has four major business segments: Canadian banking, international banking, global wealth management, and global banking and markets. It offers a range of advice, products, and services, including personal and commercial banking, wealth management and private banking, corporate and investment banking, and capital markets. The bank's international operations span numerous countries and are more concentrated in the Latin America region.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.